Karl Wittrup

CP Dubbs Professor, Chemical Engr & Bioengineering
Department
Department of Chemical Engineering
Technology Areas
Drug Discovery and Research Tools: Antibodies, Genomics & Proteomics, Animal Models, Cell Interrogation, Cell Lines & Organoids / Therapeutics: Proteins & Antibodies, Vaccines, Small Molecules / Biomaterials & Bioelectronics: Health Monitoring / Biotechnology: Sensors & Monitoring / Chemicals & Materials: Nanotechnology & Nanomaterials / Diagnostics: Assays
Impact Areas
Healthy Living

Technologies

Synergistic Tumor Treatment with Extended-PK IL-2 & Monoclonal Antibodies

Technology / Case number: #15627
Shuning (Annie) Gai / Byron Kwan / Karl Wittrup
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

Methods to Specifically Profile Protease Activity at Lymph Nodes

Technology / Case number: #18619H
Andrew Warren / Jaideep Dudani / Naveen Mehta / Sangeeta Bhatia / Darrell Irvine / Karl Wittrup
Technology Areas: Biomaterials & Bioelectronics / Biotechnology / Chemicals & Materials / Diagnostics
Impact Areas: Healthy Living
License

Cell-Surface Anchored Cytokine Therapy

Technology, Tangible Property / Case number: #25245H
Luciano Santollani / Darrell Irvine / Karl Wittrup
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

Lung-Cancer Specific T Cell Dysfunction

Technology / Case number: #23004
John Love / Stefani Spranger / Brendan Horton / Duncan Morgan / Karl Wittrup
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Single-Dose Combination Immunotherapy Augments Responses to Checkpoint Blockades for the Treatment of Cancer

Technology / Case number: #21150H
Chensu Wang / Darrell Irvine / Karl Wittrup
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

Anti-Human KLRB1 Monoclonal Antibodies and Uses Thereof

Technology / Case number: #21645J
Kai Wucherpfennig / Byong Ha Kang / Nathan Mathewson / Karl Wittrup
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Development of Multi-Specific Antibody-Serum Albumin Fusion Proteins Targeting Multiple Human and Murine CXC (ELR+) Chemokines

Technology / Case number: #19355JQ
Alessandro Angelini / Andrew Luster / Karl Wittrup
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

N/ASynergistic Tumor Treatment with IL-2, an Integrin-Binding-FC Fusion Protein, and a Cancer Vaccine

Technology / Case number: #18598HJ
Byron Kwan / Cary Opel / Kelly Moynihan / Darrell Irvine / Jennifer Cochran / Karl Wittrup
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up